4.3 Article

MFAP5 and TNNC1: Potential markers for predicting occult cervical lymphatic metastasis and prognosis in early stage tongue cancer

Journal

ONCOTARGET
Volume 8, Issue 2, Pages 2525-2535

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.12446

Keywords

potential marker; metastasis and prognosis; tongue cancer; microarray

Funding

  1. National Natural Science Foundation of China [81602367, 81602370]
  2. Science and Technology Commission of Shanghai Municipality [15411950300, 13ZR1457100]
  3. Shanghai Summit AMP
  4. Plateau Disciplines
  5. National Natural Science Foundation of China [81602367, 81602370]
  6. Science and Technology Commission of Shanghai Municipality [15411950300, 13ZR1457100]
  7. Shanghai Summit AMP
  8. Plateau Disciplines

Ask authors/readers for more resources

The purpose of this study is to identify candidate genes that could predict prognosis of early-stage tongue squamous cell carcinoma (TSCC) and its occult cervical lymphatic metastasis by large-scale gene expression profiling. Tumor tissue and matched normal mucosa samples were collected from patients with TSCC and analyzed with Affymetrix HTA2.0 high-density oligonucleotide array. Differentially expressed genes in TSCC with cervical lymph node metastasis (CLNM) were further analyzed with Gene Ontology and Kyoto Encyclopedia of Genes and Genomes for their functions and related pathways. A total of 107 differentially expressed genes (p < 0.05) were identified by microarray in TSCC samples with CLNM (n = 6) compared to those without CLNM (n = 6). Genes involved in the cell-matrix adherens junction and migration function including MFAP5, TNNC1, MGP, FBFBP1 and FBXO32 were selected and validated by RT-PCR in TSCC samples (n = 32). Of the five genes, MFAP5 and TNCC1 expressions were further validated by immohistochemistry (n = 61). The significant positive correlation between MFAP5 and TNNC1 expression (p < 0.001) was observed. Notably, over-expression of MFAP5 and TNNC1 were correlated with CLNM, metastasis relapse-free survival and overall survival. Our findings indicated that MFAP5 and TNNC1 may be potential markers for predicting occult cervical lymphatic metastasis and prognosis of oral tongue carcinoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Dentistry, Oral Surgery & Medicine

Diffuse-type tenosynovial giant cell tumor of the temporomandibular joint with skull base invasion: a report of cases with literature review

Ying Liu, Bao-hua Fan, Yi-ran Tan, Dong-wang Zhu, Min-jun Dong, Li-zhen Wang, Jiang Li, Jian Sun, Chen-ping Zhang, Tong Ji, Wen-jun Yang, Ahmed Abdelrehem, Yi-qun Wu, Lai-ping Zhong

Summary: This study retrospectively analyzed the clinical characteristics, surgical treatment, and prognosis of patients with D-TGCT involving the TMJ and the skull base. The results showed a recurrence rate of 4.5% after complete resection, and tumor recurrence rates of 9.1% and 15.8% for surgery alone and postoperative radiotherapy, respectively. Overall, D-TGCT involving the TMJ and the skull base is locally aggressive but has a good prognosis.

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2021)

Letter Oncology

Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome

Wu-tong Ju, Ying Liu, Li-zhen Wang, Jiang Li, Guo-xing Ren, Jian Sun, Wen-yong Tu, Yong-jie Hu, Tong Ji, Wen-jun Yang, Jun Li, Yue He, Yan-an Wang, Chen-ping Zhang, Lai-ping Zhong, Zhi-yuan Zhang

CANCER COMMUNICATIONS (2021)

Article Oncology

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

Claire Petit, Benjamin Lacas, Jean-Pierre Pignon, Quynh Thu Le, Vincent Gregoire, Cai Grau, Allan Hackshaw, Bjorn Zackrisson, Mahesh K. B. Parmar, Ju-Whei Lee, Maria Grazia Ghi, Giuseppe Sanguineti, Stephane Temam, Maurice Cheugoua-Zanetsie, Brian O'Sullivan, Marshall R. Posner, Everett E. Vokes, Juan J. Cruz Hernandez, Zbigniew Szutkowski, Eric Lartigau, Volker Budach, Rafal Suwinski, Michael Poulsen, Shaleen Kumar, Sarbani Ghosh Laskar, Jean-Jacques Mazeron, Branislav Jeremic, John Simes, Lai-Ping Zhong, Jens Overgaard, Catherine Fortpied, Pedro Torres-Saavedra, Jean Bourhis, Anne Auperin, Pierre Blanchard

Summary: The network meta-analysis suggests that intensifying chemoradiotherapy, using hyperfractionated radiotherapy with concomitant chemotherapy or induction chemotherapy followed by chemoradiotherapy, could improve outcomes for locally advanced head and neck cancer patients.

LANCET ONCOLOGY (2021)

Article Oncology

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

Benjamin Lacas, Alexandra Carmel, Cecile Landais, Stuart J. Wong, Lisa Licitra, Jeffrey S. Tobias, Barbara Burtness, Maria Grazia Ghi, Ezra E. W. Cohen, Cai Grau, Gregory Wolf, Ricardo Hitt, Renzo Corvo, Volker Budach, Shaleen Kumar, Sarbani Ghosh Laskar, Jean-Jacques Mazeron, Lai-Ping Zhong, Werner Dobrowsky, Pirus Ghadjar, Carlo Fallai, Branko Zakotnik, Atul Sharma, Rene-Jean Bensadoun, Maria Grazia Ruo Redda, Severine Racadot, George Fountzilas, David Brizel, Paolo Rovea, Athanassios Argiris, Zoltan Takacsi Nagy, Ju-Whei Lee, Catherine Fortpied, Jonathan Harris, Jean Bourhis, Anne Auperin, Pierre Blanchard, Jean-Pierre Pignon

Summary: The updated results of the study demonstrate the significant improvement in overall survival for head and neck cancer patients with the addition of concomitant chemotherapy, particularly for those with stage III or IV disease. Induction or adjuvant chemotherapy showed less benefit in increasing overall survival. Additionally, efficacy decreases with age progression.

RADIOTHERAPY AND ONCOLOGY (2021)

Meeting Abstract Oncology

Inductive camrelizumab and apatinib for patients with locally advanced and resectable oral squamous cell carcinoma: A single-arm trial (Icemelting trial).

Lai-Ping Zhong, Wu-tong Ju, Rong-hui Xia, Qi Zhu, Guopei Zhu, Shengjin Dou, Jiang Li, Min-jun Dong

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Dentistry, Oral Surgery & Medicine

Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5-fluorouracil combination induction chemotherapy in oral squamous cell carcinoma

Wenwen Sun, Tongchao Zhao, Timothy O. Aladelusi, Wutong Ju, Zhiyuan Zhang, Laiping Zhong, Dongwang Zhu

Summary: In patients with oral squamous cell carcinoma, reduced expression of Annexin A1 was found to enhance sensitivity to TPF chemotherapy by promoting caspase-dependent apoptosis. This indicates that Annexin A1 may have prognostic value in patients undergoing TPF chemotherapy for locally advanced OSCC.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2021)

Article Oncology

Mechanism of sensitivity to cisplatin, docetaxel, and 5-fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression

Tong-Chao Zhao, Zhi-Hang Zhou, Wu-Tong Ju, Si-Yuan Liang, Xiao Tang, Dong-Wang Zhu, Zhi-Yuan Zhang, Lai-Ping Zhong

Summary: This study found that OSCC cells overexpressing GDF15 are sensitive to TPF chemotherapy through a caspase-9-dependent pathway. GDF15 overexpression promotes OSCC cell proliferation through erbB2 phosphorylation. Therefore, ErbB2 inhibitors could be potential targeted drugs or alternative therapy for OSCC patients with GDF15 overexpression.

CANCER SCIENCE (2022)

Article Oncology

Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I

Jing Cui, Jingcheng Zhou, Weiqing He, Juan Ye, Timothy Westlake, Rogelio Medina, Herui Wang, Bhushan L. Thakur, Juanjuan Liu, Mingyu Xia, Zhonggui He, Fred E. Indig, Aiguo Li, Yan Li, Robert J. Weil, Mirit I. Aladjem, Laiping Zhong, Mark R. Gilbert, Zhengping Zhuang

Summary: In this study, a novel macrolide antibiotic ISP I was found to inhibit cancer cell growth and metastasis by targeting the nucleolar protein SELH, which is crucial for redox homeostasis and genome stability in cancer cells.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Dentistry, Oral Surgery & Medicine

Diagnosis and management of hypoglossal nerve-derived schwannoma in the floor of mouth: a case series

Jiayong Zhong, Zhihang Zhou, Yuhua Hu, Tongchao Zhao, Yu Yao, Laiping Zhong, Dongwang Zhu

Summary: This study presented the diagnosis and management of hypoglossal nerve-derived schwannoma in the floor of mouth for the first time in Asia. It provides a recommendation for considering hypoglossal schwannoma as a possible diagnosis when a patient presents with a mass in the floor of mouth.

BMC ORAL HEALTH (2022)

Article Multidisciplinary Sciences

A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma

Wu-tong Ju, Rong-hui Xia, Dong-wang Zhu, Sheng-jin Dou, Guo-pei Zhu, Min-jun Dong, Li-zhen Wang, Qi Sun, Tong-chao Zhao, Zhi-hang Zhou, Si-yuan Liang, Ying-ying Huang, Yong Tang, Si-cheng Wu, Jing Xia, Shi-qing Chen, Yue-zong Bai, Jiang Li, Qi Zhu, Lai-ping Zhong

Summary: Neoadjuvant therapy with camrelizumab and apatinib is safe and shows a promising major pathological response rate for oral squamous cell carcinoma (OSCC).

NATURE COMMUNICATIONS (2022)

Article Surgery

Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? A retrospective cohort study

Wutong Ju, Yiyi Zhang, Ying Liu, Jingjing Sun, Jiang Li, Minjun Dong, Qi Sun, Wentao Shi, Tongchao Zhao, Zhihang Zhou, Yingying Huang, Xinyu Zhou, Dongwang Zhu, Shengjin Dou, Zhiyuan Zhang, Yue He, Chenping Zhang, Ronghui Xia, Guopei Zhu, Laiping Zhong

Summary: This retrospective study compared the outcomes of adjuvant radiotherapy and nonradiotherapy in locally advanced resectable oral squamous cell carcinoma (LAROSCC) patients who received neoadjuvant therapy and surgery. The results showed no significant differences in overall survival (OS) or locoregional recurrence-free survival (LRFS) between the two cohorts. The study supports further evaluation of adjuvant radiotherapy omission and suggests de-escalation trials for LAROSCC surgery patients who received neoadjuvant therapy.

INTERNATIONAL JOURNAL OF SURGERY (2023)

Article Oncology

Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint

Ying Liu, Yingying Huang, Dongwang Zhu, Jiang Li, Tongchao Zhao, Yining He, Ronghui Xia, Laiping Zhong

Summary: This study investigated the characteristics of tumor recurrence in diffused-tenosynovial giant cell tumor of the temporomandibular joint and developed a personalized prognostic model. The results showed that age was an independent risk factor for local recurrence-free survival, and the Ki-67 index varied significantly in different sites and tumor volumes. By establishing a prediction model, the likelihood of local recurrence-free survival in patients with this tumor can be accurately forecasted.

BMC CANCER (2023)

Meeting Abstract Oncology

Neoadjuvant trial with toripalimab, albumin paclitaxel, and cisplatin on pathological response in locally advanced resectable oral squamous cell carcinoma (Illuminate Trial).

Lai-Ping Zhong, Ying-Ying Huang, Jing-Jing Sun, Jun Li, Min-Jun Dong, Guopei Zhu, Jiang Li, Wu-Tong Ju

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Targeting ERK combined with apatinib may be a promising therapeutic strategy for treating oral squamous cell carcinoma

Tong-Chao Zhao, Si-Yuan Liang, Zhi-Hang Zhou, Wu-Tong Ju, Zhi-Yuan Zhang, Dong-Wang Zhu, Lai-Ping Zhong

Summary: The study showed that Apatinib can effectively inhibit the growth of oral squamous cell carcinoma through inducing apoptosis via the VEGFR2/AKT/mTOR pathway. Apatinib also synergized with SCH772984 to achieve a more significant suppression of tumor growth.

AMERICAN JOURNAL OF CANCER RESEARCH (2021)

No Data Available